Close
CDMO Safety Testing 2026
Novotech

Schreiner MediPharm’s Pharma-Comb IL Label Supports Innovative Clinical Cancer Trial Utilizing Oncolytic Viruses

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition

Angelini Pharma has finalized a definitive agreement to acquire...

Are Glutathione Injections in NYC Worth It? A Complete Guide

When whatever you do to your skin makes it...
- Advertisement -

Schreiner MediPharm, a Germany-based globalย provider of innovative functional label solutions for the healthcare industry, isย supplying its durable Pharma-Comb IL Label solution to a company whose clinical trialย cancer medication requires low-temperature storage and pre-administration thawing,ย making marking and documentation particularly challenging.

Various clinical trials are currently focused on investigating the systematic use ofย oncolytic viruses in cancer therapies. Shanghai Yuan Song Biotechnology is among theย companies engaged in this research. For its trial relating to innovative virotherapy,ย Schreiner MediPharm supplies the appropriate specialty label, complete with variousย integrated functions, that easily withstands temperatures of -20 till -70 degrees Celsius.

Virotherapy is an immunotherapy in which patients receive injections with oncolyticย viruses. The treatment employs viruses to infect tumor cells, selectively destroyingย malignant cells. At Yuan Song Biotechnology, the active pharmaceutical ingredientย (API) for its vial-filled virotherapy cancer treatment is especially sensitive, posingย labeling challenges. The sensitive API must be stored and transported at lowย temperatures, and is subsequently thawed into a liquid before being administered.

These temperature differences place high demands on the reliable adhesion of theย marking and documentation label attached to unit-dose vials.ย In addition, prior to administering the drug, healthcare staff must check if the medicationย is flawless and the liquid is clear. A transparent inspection window must be integratedย into the label for that purpose. The label also must provide adequate space forย important information, and contain two removable parts for documenting theย administration of the medication in the patient and hospital files for the clinical trial.

For Yuan Song Biotechnology, the temperature stability and multifunctional benefits ofย Schreiner MediPharmโ€™s customized Pharma-Comb IL Label enabled reliable and clearย product marking, from storage to transportation to dispensing. The two removableย documentation labels have tabs allowing easy and efficient peel-off and attachment toย patient files. Thanks to the transparent inspection window, the vial liquid can be reliablyย checked prior to being administered. Thus, the Pharma-Comb IL Label from Schreinerย MediPharm helps optimize clinical trial processes and supports patient safety.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition

Angelini Pharma has finalized a definitive agreement to acquire...

Are Glutathione Injections in NYC Worth It? A Complete Guide

When whatever you do to your skin makes it...

Fujifilm Advances Drug Discovery with New Cyclic Peptide Screening Platform

FUJIFILM Corporation has developed a new screening methodology aimed...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป